Molecular biology was Bianca’s first love before she discovered the joys and challenges of investing. After spending some time at Swiss pharmaceuticals company Novartis.. More
Portfolio manager, Dr Bianca Ogden, drills down on two healthcare stocks, an old favourite, AstraZeneca and a more recent addition, Takeda and explains what makes them a typical Platinum stock. Investing in companies facing temporary challenges and therefore often misunderstood by the market, can deliver results for patient investors.
DISCLAIMER: This information has been prepared by Platinum Investment Management Limited ABN 25 063 565 006 AFSL 221935, trading as Platinum Asset Management ("Platinum") the investment manager of Platinum World Portfolios plc ("PWP"). Platinum World Portfolios plc ("Company") is an investment company with variable capital incorporated with limited liability in Ireland with registered number 546481 and established as an umbrella fund with segregated liability between sub-funds pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (as amended) ("UCITS Regulations").
This information is accurate at the time of publication. This information is general information only and has not been prepared taking into account any particular investor’s investment objectives, financial situation or needs, and should not be used as the basis for making an investment decision. You should obtain professional advice prior to making any investment decision. The market commentary reflects Platinum’s views and beliefs at the time of preparation, which are subject to change without notice. No representations or warranties are made by Platinum as to their accuracy or reliability. To the extent permitted by law, no liability is accepted by Platinum or any other company in the Platinum Group, including any of their directors, officers or employees, for any loss or damage arising as a result of any reliance on this information.
Investing is not without risk. Neither Platinum, any company of the Platinum Group, nor any of the respective directors and officers of the aforementioned, guarantee the performance of any investment product, strategy or fund referenced herein, the repayment of capital, or the payment of income. Past performance is not a reliable indicator of future performance.
Platinum UK Asset Management Limited ("Platinum UK") has been appointed as a sub-distributor of PWP. Platinum UK is a tied agent of Mirabella Advisers LLP, which is authorised and regulated by the Financial Conduct Authority - number 606792. The content has been approved by Mirabella Advisers LLP. In the United Kingdom, this information is aimed solely at professional clients within the meaning of Article 4.1(10) of the Markets in Financial Services Directive 2014/65/EU (MiFID II) ("Relevant Persons"). No UK person other than a Relevant Person should act or rely on this information.
Video - Andrew Clifford, CIO Talks About the World Investors are Faced with Today
Video - Andrew Clifford, CIO Talks Performance and Platinum’s Approach to Investing
Video – Speculative Market in Growth Stocks Gives Cause for Concern
This email is not registered. Please subscribe to read article.
www.platinumworldportfolios.ie, is operated by Platinum World Portfolios PLC, a variable capital investment company incorporated under the laws of Ireland under Registered Number 546481 ("the Company", “we” or “us”).
By proceeding to access, view or download information from this website, you acknowledge that you have read, and agree to be bound by, the following terms and conditions. If you do not agree to these terms and conditions, you must not use this website.